Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(22%)
Results Posted
0%(0 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
8
89%
Ph phase_2
1
11%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Not yet recruiting2
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (11.1%)
N/A8 (88.9%)

Trials by Status

completed444%
not_yet_recruiting222%
recruiting222%
terminated111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9